The UK government today launches its strategy to tackle obesity after evidence shows link with worse COVID-19 outcomes
Abbott and Tandem Diabetes Care are partnering to develop integrated diabetes solutions. The companies will combine Abbott’s continuous glucose monitoring (CGM) technology with Tandem’s insulin delivery systems.
Researchers at the University of Oxford, the University of Westminster and Perspectum Diagnostics have shown that effective assessment of the health of the liver can be done non-invasively using MRI-based imaging.
A collaboration between Sweati and Imperial College London has demonstrated a device that is capable of continuous monitoring of glucose, lactate and hydration.
Liva Healthcare has closed an €8 million investment round from three new investors: MIG, Santo Venture Capital and Digital Health Ventures. The investment will enable Liva Healthcare to scale up with existing clients, expand further geographically and continue its technological innovation.
The OneTouch Select Plus blood glucose monitoring system is the subject of a long-term study published this week in the Journal of Diabetes Science and Technology (JDST), and demonstrates the accuracy of its readings.
The digital diabetes management market is rapidly becoming a big part of the healthtech industry, reveals a market report today. It is projected to reach nearly $20 billion in sales over the next five years.